









市場
/
株式
/
nasdaq-dxcm
/

Dexcom Inc

DXCM

67.400USD

-1.030-1.51%

終値 01/09, 16:00（ET）15分遅れの株価

26.29B時価総額

36.59直近12ヶ月PER



Dexcom Inc

67.400

-1.030-1.51%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Dexcom Inc 企業名

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Dexcom Incの企業情報



企業コードDXCM

会社名Dexcom Inc

上場日Apr 14, 2005

最高経営責任者「CEO」Mr. Jacob Steven (Jake) Leach

従業員数10300

証券種類Ordinary Share

決算期末Apr 14

本社所在地6340 Sequence Drive

都市SAN DIEGO

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号92121

電話番号18582000200

ウェブサイトhttps://www.dexcom.com/

企業コードDXCM

上場日Apr 14, 2005

最高経営責任者「CEO」Mr. Jacob Steven (Jake) Leach

Dexcom Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+18200.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-4824.00%

Ms. Bridgette P. Heller

Independent Director

27.03K

-1012.00%

Mr. Kyle Malady

Independent Director

22.67K

-667.00%

Ms. Rimma Driscoll

Independent Director

9.04K

+5074.00%

Ms. Renee D. Gala

Independent Director

6.88K

+1161.00%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jacob Steven (Jake) Leach

President, Interim Principal Executive Officer, Chief Operating Officer, Director

294.46K

+18200.00%

Mr. Mark G. Foletta

Interim Independent Chairman of the Board

62.13K

+2758.00%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+2424.00%

Mr. Richard Alexander Collins

Independent Director

44.38K

+2442.00%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+2428.00%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

35.33K

-4824.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

地域別USD

会社名

収益

比率

United States

851.90M

70.45%

Outside of United states

357.40M

29.55%

事業別

地域別

事業別USD

会社名

収益

比率

Distributor

1.03B

84.84%

Direct

183.30M

15.16%

株主

更新時刻: Tue, Nov 18

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

他の

69.92%

株主統計

比率

The Vanguard Group, Inc.

12.63%

BlackRock Institutional Trust Company, N.A.

6.24%

State Street Investment Management (US)

4.32%

Baillie Gifford & Co.

4.07%

Geode Capital Management, L.L.C.

2.81%

他の

69.92%

種類

株主統計

比率

Investment Advisor

53.35%

Investment Advisor/Hedge Fund

28.86%

Hedge Fund

7.32%

Research Firm

4.05%

Pension Fund

2.14%

Bank and Trust

1.94%

Sovereign Wealth Fund

1.61%

Venture Capital

0.48%

Individual Investor

0.37%

機関投資家保有株



更新時刻: Mon, Dec 8

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

2133

390.25M

100.06%

-15.62M

2025Q3

2198

388.02M

104.56%

+4.65M

2025Q2

2236

383.14M

106.39%

+1.38M

2025Q1

2227

382.03M

104.52%

-27.81M

2024Q4

2209

376.25M

104.20%

-2.27M

2024Q3

2125

380.57M

105.64%

-16.02M

2024Q2

2097

395.55M

99.88%

+7.96M

2024Q1

2075

388.09M

102.93%

-19.55M

2023Q4

2061

396.17M

102.99%

+6.26M

2023Q3

1969

388.25M

103.58%

-414.67K

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

49.27M

12.63%

+1.13M

+2.34%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

24.32M

6.24%

+77.71K

+0.32%

Sep 30, 2025

State Street Investment Management (US)

16.86M

4.32%

-2.96K

-0.02%

Sep 30, 2025

Baillie Gifford & Co.

15.88M

4.07%

-823.03K

-4.93%

Sep 30, 2025

Geode Capital Management, L.L.C.

10.96M

2.81%

+197.42K

+1.83%

Sep 30, 2025

Jennison Associates LLC

10.09M

2.59%

-1.43M

-12.39%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

8.75M

2.24%

+531.05K

+6.46%

Dec 31, 2025

Citadel Advisors LLC

6.78M

1.74%

+5.41M

+395.24%

Sep 30, 2025

Nuveen LLC

6.15M

1.58%

-1.15M

-15.70%

Sep 30, 2025

MFS Investment Management

5.49M

1.41%

-1.00M

-15.46%

Sep 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

Mar 28, 2022

Split

1→4

日付

種類

比率

Mar 28, 2022

Split

1→4

よくある質問

Dexcom Incの上位5名の株主は誰ですか？



Dexcom Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は49.27M株を保有しており、これは全体の12.63%に相当します。
BlackRock Institutional Trust Company, N.A.は24.32M株を保有しており、これは全体の6.24%に相当します。
State Street Investment Management (US)は16.86M株を保有しており、これは全体の4.32%に相当します。
Baillie Gifford & Co.は15.88M株を保有しており、これは全体の4.07%に相当します。
Geode Capital Management, L.L.C.は10.96M株を保有しており、これは全体の2.81%に相当します。